Shang Q, Wang Y, Lu A, Jia Y, et al. Impact of pre-infusion disease burden on outcomes in pediatric relapsed/refractory B-cell lymphoblastic leukemia following anti-CD19 CAR T-cell therapy. Leuk Lymphoma 2024 Oct 8:1-10. doi: 10.1080/10428194.2024.2406958.
PMID: 39378242